Letter to the editor of Clinical Breast Cancer, on -Time to update evidence-based guideline recommendations about concurrent tamoxifen and antidepressant use? A systematic review-, conducted by Michelle Bradbury and collaborators and published in Clinical Breast Cancer April Vol 22 no.4 e362-e373, 2022